A detailed history of Trillium Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Trillium Asset Management, LLC holds 314 shares of LLY stock, worth $234,875. This represents 0.01% of its overall portfolio holdings.

Number of Shares
314
Previous 335 6.27%
Holding current value
$234,875
Previous $303,000 8.25%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$772.14 - $960.02 $16,214 - $20,160
-21 Reduced 6.27%
314 $278,000
Q1 2024

May 09, 2024

BUY
$592.2 - $792.28 $198,387 - $265,413
335 New
335 $260,000
Q4 2019

Feb 10, 2020

SELL
$106.92 - $132.43 $214,053 - $265,124
-2,002 Closed
0 $0
Q3 2019

Nov 06, 2019

BUY
$106.79 - $116.16 $213,793 - $232,552
2,002 New
2,002 $224,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Trillium Asset Management, LLC Portfolio

Follow Trillium Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trillium Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trillium Asset Management, LLC with notifications on news.